A phase II study of concurrent chemoradiotherapy with 5-fluorouracil and mitomycin-C for squamous cell carcinoma of the anal canal (the JROSG 10–2 trial)

This study assessed the efficacy of chemoradiotherapy for squamous cell carcinoma of the anal canal (SCCAC). Patients with T1–4N0-3M0 SCCAC received chemoradiotherapy with 5-fluorouracil (5-FU, 800 mg/m(2)/day, 96-h infusion) and mitomycin-C (MMC, 10 mg/m(2) bolus). Patients treated with 3-dimension...

Descripción completa

Detalles Bibliográficos
Autores principales: Murofushi, Keiko Nemoto, Itasaka, Satoshi, Shimokawa, Mototsugu, Murakami, Yuji, Yamamoto, Takaya, Nishimura, Yasumasa, Kudo, Shigehiro, Sakamoto, Takashi, Ariga, Takuro, Ogo, Etsuyo, Taguchi, Kentaro, Jingu, Keiichi, Ogawa, Kazuhiko
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2022
Materias:
Regular paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9855315/
https://www.ncbi.nlm.nih.gov/pubmed/36280895
http://dx.doi.org/10.1093/jrr/rrac069

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9855315/
https://www.ncbi.nlm.nih.gov/pubmed/36280895
http://dx.doi.org/10.1093/jrr/rrac069

Ejemplares similares